Touchlight welcomes Dr. Geoff Smith
- Posted on 19 May, 2017
Touchlight is very pleased to welcome Dr. Geoff Smith as the Head of Innovations. Geoff brings extensive experience in genomics technologies and applications, with roles including Vice President leading Technology Development at Illumina and CEO of Cambridge Epigenetix.
Geoff is a world expert in genomics technologies and their applications. He spent more than 10 years working at Solexa/Illumina, where he led the invention of many aspects of the core SBS sequencing chemistry, workflows and platforms, becoming Vice President leading Technology Development globally and clinical product development for cell-free DNA testing in pregnancy (NIPT). After leaving Illumina, Geoff was CEO of Cambridge Epigenetix, a spin-out from Cambridge University, and now works closely with a number of biotech companies in the genomics space.
Share this article:
People also read
The SynbiCITE ‘4-Day MBA, More Business Acumen’ Course
The SynbiCITE ‘4-Day MBA: More Business Acumen’ Course, 8th-12th December 2019In 2015, 35% of employers in engineering and technology-based business s...
Data-driven design and the opportunities it presents for biotech companies
Professor Paul Freemont, Co-Director of SynbiCITE, discussed the synthetic biology industry and the opportunities it is creating in a recently paper published in The Emerging Topics in Life Sciences entitled “Synthetic biology industry: data-driven design is creating new opportunities in biotechnology”.
The Cell Factories of the Future
Professor Paul Freemont, Co-Director of SynbiCITE, is the lead author of a recent article published by the World Economic Forum on this subject, entitled “How scientists are turning living cells into the tiny factories of the future”.